Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-11 | Nuvation Bio Inc. | Wang Junyuan Jerry
(CEO, ANHEART THERAPEUTICS LTD.) |
S | Class A Common Stock | D | 56361 | $2.89 - $2.89 | $162,883 |
| 2024-10-08 | Nuvation Bio Inc. | Mashal Robert
(Director) |
P | Class A Common Stock | A | 100000 | $2.19 - $2.20 | $219,999 |
| 2024-06-25 | Nuvation Bio Inc. | Cui Xiangmin
(Director) |
P | Class A Common Stock | A | 277895 | $2.97 - $2.97 | $825,348 |
| 2024-06-20 | Nuvation Bio Inc. | Cui Xiangmin
(Director) |
P | Class A Common Stock | A | 500000 | $2.98 - $3.00 | $1,492,384 |
| 2024-05-24 | Nuvation Bio Inc. | WELCH DANIEL G
(Director) |
M | Class A Common Stock | A | 659947 | $1.64 - $1.74 | $1,111,633 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |